137 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30673966 | Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer. | 2019 Jun | 1 |
2 | 29931401 | Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. | 2018 Jul | 1 |
3 | 30345049 | Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study. | 2018 Nov | 1 |
4 | 26715117 | Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. | 2017 Jan | 1 |
5 | 27189323 | A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer. | 2017 Mar | 1 |
6 | 27255289 | Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer. | 2017 Mar | 1 |
7 | 27980246 | Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer. | 2017 Jan | 1 |
8 | 28760152 | Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study. | 2017 Jul 31 | 1 |
9 | 28794362 | Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine. | 2017 Sep 1 | 1 |
10 | 29191594 | A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202. | 2017 Oct | 1 |
11 | 29696197 | Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial. | 2017 Dec | 1 |
12 | 26606381 | A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer. | 2016 | 1 |
13 | 26830752 | Pancreatic cancer. | 2016 Jul 2 | 1 |
14 | 26915359 | Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. | 2016 Feb 25 | 1 |
15 | 27067680 | [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer]. | 2016 Feb | 1 |
16 | 27207886 | Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701. | 2016 Aug | 1 |
17 | 27339150 | Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer. | 2016 Aug | 1 |
18 | 27468920 | Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study). | 2016 Sep | 1 |
19 | 25422155 | Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer. | 2015 Jan | 1 |
20 | 26019463 | Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. | 2015 May 21 | 1 |
21 | 24258457 | A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer. | 2014 Feb | 1 |
22 | 24895802 | Phase I trial of preoperative chemoradiation therapy with S-1 for low rectal cancer. | 2014 Jan-Feb | 1 |
23 | 24918280 | [Case report of a patient with advanced and disseminated gastric carcinoma treated by s-1]. | 2014 | 1 |
24 | 24942277 | S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial). | 2014 Sep | 1 |
25 | 25032886 | Efficacy of S-1 in colorectal cancer. | 2014 Aug | 1 |
26 | 25109221 | Efficacy of S-1 in non-small cell lung cancer. | 2014 Sep | 1 |
27 | 25453619 | Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer. | 2014 Dec | 1 |
28 | 25606031 | Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin. | 2014 Sep-Dec | 1 |
29 | 22623066 | A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer. | 2013 Jun | 1 |
30 | 23558513 | Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer. | 2013 Jun 15 | 1 |
31 | 23763511 | Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). | 2013 Sep | 1 |
32 | 23898376 | Chemotherapy for advanced gastric cancer: review and update of current practices. | 2013 Jul | 1 |
33 | 23963147 | S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis. | 2013 Sep 17 | 1 |
34 | 24649158 | A phase II study of S-1 in relapsed small cell lung cancer. | 2013 Mar | 1 |
35 | 21351099 | Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer. | 2012 Jan 15 | 1 |
36 | 21647560 | A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer. | 2012 Mar | 1 |
37 | 22172569 | A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer. | 2012 Mar | 1 |
38 | 22235991 | S-1 as a core anticancer fluoropyrimidine agent. | 2012 Mar | 1 |
39 | 22353201 | Pharmacokinetic study of weekly (days 1-5) low-dose S-1 in patients with non-small-cell lung cancer. | 2012 May | 1 |
40 | 22424872 | A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. | 2012 Nov | 1 |
41 | 22740921 | S-1 monotherapy for previously treated non-small cell lung cancer: A retrospective analysis by age and histopathological type. | 2012 Feb | 1 |
42 | 22860709 | S-1 for the treatment of gastrointestinal cancer. | 2012 Sep | 1 |
43 | 22953663 | Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer. | 2012 Aug | 2 |
44 | 22996786 | [A case report of S-1 monotherapy for advanced hepatocellular carcinoma]. | 2012 Sep | 1 |
45 | 20605363 | Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. | 2011 May 1 | 1 |
46 | 21143703 | Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients. | 2011 Feb | 1 |
47 | 21187666 | Concurrent chemoradiotherapy with S-1 as first-line treatment for patients with oropharyngeal cancer. | 2011 | 1 |
48 | 21325974 | Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer. | 2011 Apr | 1 |
49 | 21659785 | Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302). | 2011 | 1 |
50 | 21675835 | A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. | 2011 Jun | 2 |